12Sep/13

Gilead leaps ahead with FDA app for PI3K cancer killer – FierceBiotech

Gilead leaps ahead with FDA app for PI3K cancer killer
FierceBiotech
As the biotech giant had said was a possibility, Gilead is seeking an early approval for idelalisib to combat indolent cases of non-Hodgkin’s lymphoma (NHL) that fail to respond to rituximab and alkylating-agent chemotherapies. Foster City, CA-based
Gilead Seeks FDA Approval for IdelalisibYahoo! News
Idelalisib NDA Submitted for Indolent Non-Hodgkin’s LymphomaMonthly Prescribing Reference
Gilead Submits NDA for IdelalisibDrug Discovery & Development
PharmaTimes
all 8 news articles »
12Sep/13

'New pacemaker system offers more options for patients with heart failure' – Times of India

‘New pacemaker system offers more options for patients with heart failure
Times of India
Explaining how quadripolar technology works, Dr Anil Saxena of New Delhi-based Fortis Escorts Hospital says, “Historically, pacing systems that treat heart failure included a lead with only one electrode in the heart. Later, these were replaced by
US firm brings next generation pacemaker in IndiaPress Trust of India

all 2 news articles »

12Sep/13

மூளைச்சாவு அடைந்த பெண் உடல் … – மாலை மலர்

மூளைச்சாவு அடைந்த பெண் உடல்
மாலை மலர்
சென்னை ஓட்டல் அதிபர் ரகுபதி. இவரது மனைவி மல்லீஸ்வரி (57). வட மாநில திருக்கோவில்களுக்கு புனித யாத்திரை சென்று திரும்பினார். திடீரென்று